Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro
- 31 August 2010
- journal article
- Published by Elsevier in Biomaterials
- Vol. 31 (22), 5741-5748
- https://doi.org/10.1016/j.biomaterials.2010.03.074
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1-R01-HL079184)
- Canadian Institutes of Health Research (MOP-93773)
This publication has 38 references indexed in Scilit:
- Lessons learned from the contamination of heparinNatural Product Reports, 2009
- Analysis of heparin sodium by SAX/HPLC for contaminants and impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2008
- Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfateBlood Coagulation & Fibrinolysis, 2008
- The FDA and safety—beyond the heparin crisisNature Biotechnology, 2008
- Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsNature Biotechnology, 2008
- Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogenBlood Coagulation & Fibrinolysis, 2008
- Generation of kinins during preparation and storage of whole blood–derived platelet concentratesTransfusion, 2007
- Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator TreatmentStroke, 2002
- Activation of the kallikrein-kinin system in hemodialysis: Role of membrane electronegativity, blood dilution, and pHKidney International, 1999
- The Activation of the Contact System of Human Plasma by Polysaccharide SulfatesAnnals of the New York Academy of Sciences, 1987